Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Medpace Holdings, Inc. (MEDP : NSDQ)
 
 • Company Description   
Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio.

Number of Employees: 5,900

 
 • Price / Volume Information   
Yesterday's Closing Price: $589.15 Daily Weekly Monthly
20 Day Moving Average: 350,886 shares
Shares Outstanding: 28.17 (millions)
Market Capitalization: $16,595.31 (millions)
Beta: 1.42
52 Week High: $625.00
52 Week Low: $250.05
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 17.54% 14.46%
12 Week 28.68% 23.34%
Year To Date 77.33% 55.01%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5375 MEDPACE WAY
-
CINCINNATI,OH 45227
USA		 ph: 513-579-9911
fax: 513-579-0444		 investor@medpace.com http://www.medpace.com
 
 • General Corporate Information   
Officers
August J. Troendle - Chief Executive Officer and Chairman of the Board
Kevin M. Brady - Chief Financial Officer
Brian T. Carley - Director
Robert O. Kraft - Director
Fred B. Davenport Jr. - Director

Peer Information
Medpace Holdings, Inc. (CHCR)
Medpace Holdings, Inc. (ESRX)
Medpace Holdings, Inc. (MYDP)
Medpace Holdings, Inc. (COR)
Medpace Holdings, Inc. (GBCS)
Medpace Holdings, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 58506Q109
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/09/26
Share - Related Items
Shares Outstanding: 28.17
Most Recent Split Date: (:1)
Beta: 1.42
Market Capitalization: $16,595.31 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $4.18 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $14.79 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 14.78% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/09/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 39.84
Trailing 12 Months: 41.20
PEG Ratio: 2.70
Price Ratios
Price/Book: 56.52
Price/Cash Flow: 42.23
Price / Sales: 7.04
EPS Growth
vs. Year Ago Period: 28.24%
vs. Previous Quarter: 24.52%
Sales Growth
vs. Year Ago Period: 23.74%
vs. Previous Quarter: 9.38%
ROE
09/30/25 - 91.88
06/30/25 - 67.66
03/31/25 - 54.36
ROA
09/30/25 - 23.65
06/30/25 - 21.86
03/31/25 - 20.81
Current Ratio
09/30/25 - 0.57
06/30/25 - 0.43
03/31/25 - 0.73
Quick Ratio
09/30/25 - 0.57
06/30/25 - 0.43
03/31/25 - 0.73
Operating Margin
09/30/25 - 18.36
06/30/25 - 18.74
03/31/25 - 19.31
Net Margin
09/30/25 - 18.36
06/30/25 - 18.74
03/31/25 - 19.31
Pre-Tax Margin
09/30/25 - 22.02
06/30/25 - 22.20
03/31/25 - 22.32
Book Value
09/30/25 - 10.43
06/30/25 - 6.14
03/31/25 - 20.65
Inventory Turnover
09/30/25 - -
06/30/25 - -
03/31/25 - -
Debt-to-Equity
09/30/25 - 0.00
06/30/25 - 0.00
03/31/25 - 0.00
Debt-to-Capital
09/30/25 - 0.00
06/30/25 - 0.00
03/31/25 - 0.00
 

Powered by Zacks Investment Research ©